New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 12, 2012
14:05 EDTNEPTNeptune Technologies says trading on NASDAQ, TSX remains halted indefinitely
Trading of Neptune's common shares on the NASDAQ Stock Market and the Toronto Stock Exchange, or TSX, has currently been halted indefinitely, pending further information. A trading halt is imposed at the discretion of the stock exchanges, and lifting of a trading halt is equally subject to the discretion of the stock exchanges. Neptune currently anticipates that the trading halts on its common shares will not be lifted until such time when additional information is disclosed on Neptune's plans going forward and NASDAQ and the TSX are satisfied that investors have sufficient information on the business and operations of Neptune going forward to make informed investment decisions.
News For NEPT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 23, 2015
19:10 EDTNEPTNeptune, Acasti announce USPTO decision that triggers royalty payments
Neptune Technologies & Bioressources (NEPT) and Acasti Pharma (ACST) announced that the Patent Trial and Appeal Board of the U.S. Patent and Trademark Office, or USPTO, issued a favorable decision, confirming the validity of certain claims in Neptune's '351 patent and triggering royalty payments to Neptune. "This is a significant milestone that triggers the payment of ongoing royalties to Neptune by Aker and Enzymotec, based on their sales of licensed krill oil products in the US," said Neptuine CEO Jim Hamilton.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use